Related Experiment Video
Updated: Oct 14, 2025

Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound
Published on: August 4, 2022
Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous
Chen Chu1, Lan He1, Yi-Xiang Lin1
1Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, 399 Wan Yuan Road, Shanghai, 201102, China.
Insights
Kawasaki disease can cause rare peripheral artery aneurysms alongside coronary artery aneurysms. Prompt antithrombotic therapy is crucial for managing these systemic artery aneurysms and preventing complications.
Area of Science:
- Cardiovascular Medicine
- Pediatric Rheumatology
- Vascular Surgery
Background:
- Kawasaki disease (KD) is a vasculitis affecting medium-sized arteries, primarily causing coronary artery aneurysms (CAAs).
- Peripheral systemic artery aneurysms (SAAs) are rare complications of KD, often associated with severe or refractory cases.
- Thrombotic events in SAAs are infrequently reported in the literature.
Purpose of the Study:
- To report a case of giant bilateral axillary artery aneurysms (AAAs) in a pediatric patient with a history of Kawasaki disease.
- To emphasize the importance of evaluating for peripheral SAAs in KD patients, even those with seemingly uncomplicated coronary artery aneurysms.
- To highlight the critical role of antithrombotic therapy in managing both CAAs and SAAs in KD.
Main Methods:
- A 10-month-old boy with KD and bilateral CAAs presented with suspected axillary artery pseudoaneurysms.
- Diagnostic imaging included echocardiogram, ultrasound, and angiography to assess the extent of aneurysms and thrombus formation.
- Treatment involved prostaglandin, aspirin, low molecular weight heparin/warfarin, and metoprolol to promote collateral circulation and prevent thrombosis.
Main Results:
- The patient was diagnosed with giant bilateral AAAs, with the left AAA showing complete occlusion and significant thrombus.
- Medical management led to significant improvement in the left upper limb's temperature and movement.
- Follow-up at 7 months showed continued improvement and no cardiovascular events, with stable aneurysm imaging.
Conclusions:
- Peripheral SAAs should be evaluated in all Kawasaki disease patients with CAAs, irrespective of treatment course.
- Antithrombotic therapy is essential for managing both large non-aortic SAAs and CAAs in KD.
- Early detection and management of SAAs can prevent severe complications and improve patient outcomes.
Background:
Kawasaki disease (KD) is a systemic vasculitis that predominantly affects medium-sized arteries. In addition to well-known coronary artery aneurysms (CAAs), peripheral systemic artery aneurysms (SAAs) have also been sporadically reported. In the literatures, SAAs occurred mainly in untreated, intravenous immunoglobin (IVIG)-resistant, or severe refractory KD, and thrombotic events in SAAs were rarely reported.
Case Presentation:
A 10-month-old boy with a history of KD was referred to our hospital for suspected pseudoaneurysm of the axillary arteries. Four months prior to presentation, he had persistent fever, conjunctival congestion, and rash. On the 10th day of fever echocardiogram showed biliteral CAAs. He was then diagnosed with KD and given IVIG 2 g/kg and aspirin at a local hospital. His fever and symptoms soon subsided and he was discharged with low dose aspirin and dipyridamole. One month prior to presentation, his parents incidentally palpated swellings in his bilateral axillae. On admission, physical examination revealed a pulsatile swelling in his right axilla and a non-pulsatile swelling in the left with impalpable left brachial and radial pulses, cooler and less active left upper limb than the right one. While the pulses of other three limbs were normal. Ultrasound examination revealed giant bilateral axillary artery aneurysms (AAAs) with massive thrombus in the left. Angiography confirmed giant bilateral AAAs with left AAAs completely occluded and fine collateral vessels connecting to the distal brachial artery, in addition to giant bilateral multiple CAAs without stenoses. The patient was given intravenous prostaglandin for 10 days to allow for formation of collateral circulation, as well as aspirin, low molecular weight heparin (which was switched to warfarin before discharge) and metoprolol. At discharge, the temperature and movement of his left upper limb improved significantly. On follow-up at 7 months, his left upper limb further improved and was similar to the right with no occurrence of cardiovascular events. The images of CAAs and AAAs on echocardiogram and computerized tomography remained the same.
Conclusions:
This case highlights the importance of evaluating peripheral SAAs in KD patients with CAAs, even if their course of treatment appears smooth. For both large non-aortic SAAs and CAAs in KD patients, antithrombotic therapy is of utmost importance.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
07:21Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
Published on: September 8, 2023
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis